Asset

Total 8, page 1/1

No. Organization Therapeutic Area Product Type Title
45 Dana-Farber Neurology, Oncology Small molecule Selective Disruption of Histone Deacetylase Complexes by Protein Interaction Inhibitors to Treat Cancer and Neurological Disorders
39 Dana-Farber Oncology Small molecule KDM5 Selective Inhibitors for the Treatment of Multiple Myeloma and Other KDM-dependent Diseases
38 Dana-Farber Oncology Small molecule Highly Selective Focal Adhesion Kinase (FAK) Inhibitors
37 Dana-Farber Oncology Small molecule Targeting TIRR for Cancer Therapy: A Novel Target for p53 Reactivation
36 Dana-Farber Oncology Small molecule Small molecules that Block Proteasome-Associated Ubiquitin Receptor RPN13 Function
23 Dana-Farber Oncology Cell therapy LMP1 Based Approach to Producing Multi-specific CD4+ CTLs for Cancer Immunotherapy
22 Dana-Farber Oncology Nucleotide Antisense Inhibitors of Long Noncoding RNA as Treatment for Multiple Myeloma
13 Dana-Farber Immunology, Oncology Small molecule CDK8 and CDK19 Small Molecule Inhibitors and Degraders

TOP